Literature DB >> 17909563

Mycobacterium tuberculosis secretory proteins CFP-10, ESAT-6 and the CFP10:ESAT6 complex inhibit lipopolysaccharide-induced NF-kappaB transactivation by downregulation of reactive oxidative species (ROS) production.

Niladri Ganguly1, Pham H Giang, Chitra Gupta, Sandip K Basu, Imran Siddiqui, Dinakar M Salunke, Pawan Sharma.   

Abstract

Mycobacterium tuberculosis (Mtb) causes death of 2-3 million people annually and is considered one of the most successful intracellular pathogens to persist inside the host macrophage. Recent studies have implicated the role of RD-1 region of Mtb genome in the mycobacterial pathogenesis. The role of RD-1-encoded secretory proteins of Mtb in modulation of macrophage function has not been investigated in detail. Here we show that RD-1 encoded two major secretory proteins, namely, culture filtrate protein-10 kDa (CFP-10) and early secreted antigenic target-6 kDa (ESAT-6), and their 1:1 CFP-10:ESAT6 complex inhibit production of reactive oxidative species (ROS) in RAW264.7 cells. These proteins also downregulated the bacterial lipopolysaccharide (LPS)-induced ROS production, which, in turn, downregulated LPS-induced nuclear factor-kappaB (NF-kappaB) p65 DNA-binding activity, as well as inhibited the NF-kappaB-dependent reporter gene (chloramphenicol acetyl transferase) expression in the treated macrophages. Moreover, addition of N-acetyl cysteine, which is a scavenger of ROS, also inhibited LPS-induced reporter gene expression by scavenging the ROS, thereby preventing NF-kappaB transactivation. These studies indicate that the secretory proteins CFP-10, ESAT-6 and the CFP10:ESAT6 complex of Mtb can inhibit LPS-induced NF-kappaB-dependent gene expression via downregulation of ROS production.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17909563     DOI: 10.1038/sj.icb.7100117

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  32 in total

Review 1.  Immune regulatory activities of early secreted antigenic target of 6-kD protein of Mycobacterium tuberculosis and implications for tuberculosis vaccine design.

Authors:  Buka Samten; Xisheng Wang; Peter F Barnes
Journal:  Tuberculosis (Edinb)       Date:  2011-12-09       Impact factor: 3.131

2.  Hydrophilic Acylated Surface Protein A (HASPA) of Leishmania donovani: Expression, Purification and Biophysico-Chemical Characterization.

Authors:  Manoj Kumar; Kishu Ranjan; Vijay Singh; Chandramani Pathak; Anju Pappachan; Desh Deepak Singh
Journal:  Protein J       Date:  2017-08       Impact factor: 2.371

3.  NOD2 controls the nature of the inflammatory response and subsequent fate of Mycobacterium tuberculosis and M. bovis BCG in human macrophages.

Authors:  Michelle N Brooks; Murugesan V S Rajaram; Abul K Azad; Amal O Amer; Martin A Valdivia-Arenas; Jong-Hwan Park; Gabriel Núñez; Larry S Schlesinger
Journal:  Cell Microbiol       Date:  2010-11-24       Impact factor: 3.715

Review 4.  Bacterial manipulation of innate immunity to promote infection.

Authors:  Lautaro Diacovich; Jean-Pierre Gorvel
Journal:  Nat Rev Microbiol       Date:  2010-02       Impact factor: 60.633

5.  Mycobacterium tuberculosis suppresses innate immunity by coopting the host ubiquitin system.

Authors:  Jing Wang; Bing-Xi Li; Pu-Pu Ge; Jie Li; Qi Wang; George Fu Gao; Xiao-Bo Qiu; Cui Hua Liu
Journal:  Nat Immunol       Date:  2015-02-02       Impact factor: 25.606

6.  A mycobacterial phosphoribosyltransferase promotes bacillary survival by inhibiting oxidative stress and autophagy pathways in macrophages and zebrafish.

Authors:  Soumitra Mohanty; Lakshmanan Jagannathan; Geetanjali Ganguli; Avinash Padhi; Debasish Roy; Nader Alaridah; Pratip Saha; Upendra Nongthomba; Gabriela Godaly; Ramesh Kumar Gopal; Sulagna Banerjee; Avinash Sonawane
Journal:  J Biol Chem       Date:  2015-03-30       Impact factor: 5.157

7.  Safety of Recombinant Fusion Protein ESAT6-CFP10 as a Skin Test Reagent for Tuberculosis Diagnosis: an Open-Label, Randomized, Single-Center Phase I Clinical Trial.

Authors:  Feng Li; Miao Xu; Lijun Zhou; Yanqing Xiong; Lu Xia; Xiaoyong Fan; Jun Gu; Jiang Pu; Shuihua Lu; Guozhi Wang
Journal:  Clin Vaccine Immunol       Date:  2016-09-06

8.  CFP-10 from Mycobacterium tuberculosis selectively activates human neutrophils through a pertussis toxin-sensitive chemotactic receptor.

Authors:  Amanda Welin; Halla Björnsdottir; Malene Winther; Karin Christenson; Tudor Oprea; Anna Karlsson; Huamei Forsman; Claes Dahlgren; Johan Bylund
Journal:  Infect Immun       Date:  2014-10-20       Impact factor: 3.441

9.  Development of a novel anti ESAT-6 monoclonal antibody for screening of Mycobacterium tuberculosis.

Authors:  Jianhang Leng; Yu Ding; Chengmin Shou; Zhigang Wu; Guangchao Zhuo; Keyi Wang; Junya Shen; Sheng Huang
Journal:  Int J Clin Exp Med       Date:  2014-11-15

10.  Mycobacterial ESX-1 secretion system mediates host cell lysis through bacterium contact-dependent gross membrane disruptions.

Authors:  William H Conrad; Morwan M Osman; Jonathan K Shanahan; Frances Chu; Kevin K Takaki; James Cameron; Digby Hopkinson-Woolley; Roland Brosch; Lalita Ramakrishnan
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.